Video Experimental Relacionado

Updated: May 7, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.5K

Condicionamiento isquémico remoto en enterocolitis necrosante: un estudio de seguridad extendido de fase I

Yongfang Wu1, Niloofar Ganji2, Zhou Chen3

  • 1Neonatal Medical Center, Children's Hospital of Fudan University (Xiamen Branch), Xiamen Children's Hospital, Fujian, 361006, China.

Pediatric surgery international
|December 20, 2025
PubMed
Resumen

El condicionamiento isquémico remoto (RIC) es seguro para los bebés prematuros con enterocolitis necrosante (NEC). Este estudio confirma la seguridad del RIC en neonatos, incluso con la aplicación prolongada tanto para casos médicos como quirúrgicos de NEC.

Palabras clave:
enterocolitis necrosantecondicionamiento isquémico remotoestudio de seguridad

Más Videos Relacionados

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

7.9K
Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury07:17

Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury

Published on: March 22, 2024

1.6K

Videos de Conceptos Relacionados

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.